检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A phase I first-in-human study of PRTH-101, an IgG1 monoclonal antibody targeting DDR1, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies

S. Sen,A. I. Spira,D. Sommerhalder, F. Meric-Bernstam, V. Subbiah,J. D. Berlin,A. Parikh, M. Cecchini,R. E. Sanborn, P. V. Chablani,G. E. Peoples, T. Schurpf, L. A. Dillon,G. T. Clifton,J. P. Eder,A. W. Tolcher

ANNALS OF ONCOLOGY（2023）

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要